| Valsartan for prevention of recurrent atrial fibrillation GISSI-AF Investigators New England Journal of Medicine 360 (16), 1606-1617, 2009 | 604 | 2009 |
| A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis S Mazza, A Sorce, F Peyvandi, M Vecchi, F Caprioli Gut 69 (6), 1148-1149, 2020 | 97 | 2020 |
| Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn’s disease treated with anti-tumour necrosis factor antibodies S Orlando, M Fraquelli, M Coletta, F Branchi, A Magarotto, CB Conti, ... Journal of Crohn's and Colitis 12 (1), 63-70, 2018 | 72 | 2018 |
| Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative … G Leccese, A Bibi, S Mazza, F Facciotti, F Caprioli, P Landini, M Paroni Cells 9 (8), 1824, 2020 | 51 | 2020 |
| Experience with early sorafenib treatment with mTOR inhibitors in hepatocellular carcinoma recurring after liver transplantation F Invernizzi, M Iavarone, C Zavaglia, S Mazza, U Maggi, L Cesarini, ... Transplantation 104 (3), 568-574, 2020 | 45 | 2020 |
| Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy R Berte’, S Mazza, MR Stefanucci, D Noviello, S Costa, C Ciafardini, ... Journal of Crohn's and Colitis 15 (5), 864-868, 2021 | 33 | 2021 |
| Immunological variables associated with clinical and endoscopic response to vedolizumab in patients with inflammatory bowel diseases M Coletta, M Paroni, MF Alvisi, M De Luca, E Rulli, S Mazza, F Facciotti, ... Journal of Crohn's and Colitis 14 (9), 1190-1201, 2020 | 26 | 2020 |
| Trust in telemedicine from IBD outpatients during the COVID-19 pandemic A Costantino, D Noviello, S Mazza, R Berté, F Caprioli, M Vecchi Digestive and Liver Disease 53 (3), 291-294, 2021 | 24 | 2021 |
| Regorafenib efficacy after sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation: a retrospective study M Iavarone, F Invernizzi, T Ivanics, S Mazza, C Zavaglia, ... Liver Transplantation 27 (12), 1767-1778, 2021 | 23 | 2021 |
| Lower incidence of COVID‐19 in patients with inflammatory bowel disease treated with non‐gut selective biologic therapy S Ardizzone, F Ferretti, MC Monico, AM Carvalhas Gabrielli, ... Journal of Gastroenterology and Hepatology 36 (11), 3050-3055, 2021 | 20 | 2021 |
| Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: a multicenter retrospective study A Viola, D Pugliese, S Renna, F Furfaro, F Caprioli, R D’Incà, F Bossa, ... Digestive and Liver Disease 51 (4), 510-515, 2019 | 18 | 2019 |
| P360 Safety and clinical efficacy of double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): a … S Mazza, A Fasci, V Casini, C Ricci, F Munari, L Pirola, C Girelli, ... Journal of Crohn's and Colitis 14 (Supplement_1), S342-S342, 2020 | 14 | 2020 |
| Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT‐P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter … S Mazza, N Piazza O. Sed, FS Conforti, A Fascì, A Rimondi, B Marinoni, ... Clinical and Translational Science 15 (1), 172-181, 2022 | 13 | 2022 |
| Blood bacterial DNA load and profiling differ in colorectal cancer patients compared to tumor-free controls M Mutignani, R Penagini, G Gargari, S Guglielmetti, M Cintolo, A Airoldi, ... Cancers 13 (24), 6363, 2021 | 13 | 2021 |
| A comprehensive review on bariatric endoscopy: where we are now and where we are going A Mauro, F Lusetti, D Scalvini, M Bardone, F De Grazia, S Mazza, L Pozzi, ... Medicina 59 (3), 636, 2023 | 11 | 2023 |
| Gastric per-oral endoscopic myotomy: Indications, technique, results and comparison with surgical approach MC Verga, S Mazza, F Azzolini, F Cereatti, CB Conti, A Drago, S Soro, ... World Journal of Gastrointestinal Surgery 14 (1), 12, 2022 | 9 | 2022 |
| Liver-side of inflammatory bowel diseases: hepatobiliary and drug-induced disorders S Mazza, S Soro, MC Verga, B Elvo, F Ferretti, F Cereatti, A Drago, ... World Journal of Hepatology 13 (12), 1828, 2021 | 9 | 2021 |
| Agreement between real-time elastography and delayed enhancement magnetic resonance enterography on quantifying bowel wall fibrosis in Crohn's disease S Mazza, FS Conforti, LV Forzenigo, N Piazza, R Bertè, A Costantino, ... Digestive and Liver Disease 54 (1), 69-75, 2022 | 8 | 2022 |
| The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: a multicenter study F Ferretti, MC Monico, R Cannatelli, S Carmagnola, MV Lenti, ... Frontiers in Medicine 9, 933357, 2022 | 7 | 2022 |
| Endoscopic ultrasound diagnostic gain over computed tomography and magnetic resonance cholangiopancreatography in defining etiology of idiopathic acute pancreatitis S Mazza, B Elvo, CB Conti, A Drago, MC Verga, S Soro, A De Silvestri, ... World Journal of Gastrointestinal Endoscopy 14 (6), 0, 2022 | 6 | 2022 |
